title: Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein.
authors.forename: Reynaria
authors.initials: R
authors.lastname: Pitts
authors.forename: Elise
authors.initials: E
authors.lastname: Gunzburger
authors.forename: Christie M
authors.initials: CM
authors.lastname: Ballantyne
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Barter
authors.forename: David
authors.initials: D
authors.lastname: Kallend
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Leiter
authors.forename: Eran
authors.initials: E
authors.lastname: Leitersdorf
authors.forename: John J V
authors.initials: JJ
authors.lastname: McMurray
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Nicholls
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Niesor
authors.forename: Anders G
authors.initials: AG
authors.lastname: Olsson
authors.forename: Prediman K
authors.initials: PK
authors.lastname: Shah
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Tardif
authors.forename: John
authors.initials: J
authors.lastname: Kittelson
authors.forename: Gregory G
authors.initials: GG
authors.lastname: Schwartz
mesh_terms: D000577:Amides; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D002097:C-Reactive Protein / Q000032:analysis*; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors; D008076:Cholesterol, HDL / Q000032:analysis*; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control; D004952:Esters; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D013438:Sulfhydryl Compounds / Q000008:administration & dosage*
chemical_list: D000577:Amides; D000924:Anticholesteremic Agents; C506642:CETP protein, human; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D004952:Esters; D013438:Sulfhydryl Compounds; C411602:dalcetrapib; D002097:C-Reactive Protein